@onwdempowered ONWARD MedicalONWARD Medical posts on X about movement, we are, ceo, $dave the most. They currently have [-------] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence travel destinations countries currencies finance financial services stocks events
Social topic influence movement, we are, ceo, $dave, sci, bci, arc, $onwry, approval, new york
Top accounts mentioned or mentioned by @reevefoundation @onwddave @neurorestore @chuvlausanne @gcourtine @epflen @tijd @nature @iscosmeetings @shepherdcenter @janssenthomas1 @onwdcom @maartenskliniek @neuralinks @ieeeembs @vlfedbeleggers @jocelynebloch @time @eueic @kbcsecurities
Top assets mentioned Dave Inc. (DAVE)
Top posts by engagements in the last [--] hours
"We are pleased to announce ONWARD has obtained IP rights to develop innovations using Brain-Spine Interface technology that have the promise to further our therapies for mobility. Thanks to partners @EPFL @CHUVLausanne @_NeuroRestore #braininterface #bci #sci #neurotech #medtech"
X Link 2022-03-28T08:52Z [----] followers, [--] engagements
"@onwdempowered CEO @DaveMarver and CFO Lara Smith-Weber will participate in the KBC Securities Life Sciences conference tomorrow. They look forward to sharing our positive Up-LIFT pivotal study top-line results with the many US institutional investors @kbc_group brings together"
X Link 2022-09-14T08:21Z [----] followers, [--] engagements
"We are proud to announce that we have launched a partnership with Lovell Government Services a Service-Disabled Veteran-Owned Small Business (SDVOSB). The two-year distribution agreement provides our Company with access to the United States Veterans Health Administration the worlds largest healthcare system providing spinal cord injury care and the US Department of Defense Military Health System the world's largest military healthcare provider. Lovell will add our therapies to its relevant federal contracts once those technologies are authorized by the US Food and Drug Administration for sale"
X Link 2023-09-13T17:15Z [----] followers, [---] engagements
"We look forward to attending the ESSFN Congress in Stockholm Sweden next week On Thursday our research partners @EPFL_en and @CHUVLausanne neuroscientist @gcourtine and neurosurgeon Jocelyne Bloch will speak on walking naturally after spinal cord injury using our ARC"
X Link 2023-09-21T00:42Z [----] followers, [--] engagements
"Christopher Reeve was a hero in so many ways. Today on what would have been his 71st birthday we remember his courage dedication and advocacy for the spinal cord injury community. The @ReeveFoundation carries on the Reeve familys legacy in deep and meaningful ways. We are honored to work with such an impactful organization. #EmpoweringMovement #SCI"
X Link 2023-09-25T20:41Z [----] followers, [---] engagements
"Last week we attended the ESSFN Congress in Stockholm Sweden. Our Marketing team members Francesca de Santi and Rob Nijs enjoyed connecting with those of you in attendance and discussing ARC Therapy*. Francesca shared that attendees were "intrigued by ARC Therapy and the potential to positively impact symptoms after spinal cord injury (SCI)." There was also buzz about the keynote from @EPFL_en and @CHUVLausanne neuroscientist @gcourtine and neurosurgeon Jocelyne Bloch featuring the use of ARC Therapy in combination with a brain-spine interface. If you are interested in learning more about our"
X Link 2023-10-04T18:09Z [----] followers, [---] engagements
"Our team is packing our bags to connect with you at the 62nd @ISCoSmeetings Annual Scientific Meeting in Edinburgh Scotland next week โ Join our Expert Session and Live Q&A hosted by Dr. Edelle Field-Fote from the @ShepherdCenter in Atlanta and Prof. dr. @Janssen_Thomas1 from @Reade_020 in Amsterdam Noord-Holland on Tuesday October 10th at 12:50pm BST. We are also eagerly anticipating connecting with our friends from Wings for Life and @SpinalResearch - leading organizations that support research and innovation for individuals and families impacted by paralysis. Visit Booth #15 to say hello"
X Link 2023-10-06T16:36Z [----] followers, [---] engagements
"๐ We loved knowledge sharing during @ISCoSmeetings Thank you to all who attended our Developing Breakthrough Therapies* for People with SCI expert session hosted by Dr. Edelle Field-Fote and Prof. dr. @Janssen_Thomas1. Panelists Dr. Field-Fote Prof. dr. Janssen and Dr. @ilsevannes as well as our CEO Dave Marver appreciated the thought-provoking questions and lively participation If you would like to learn more about ARC Therapy* or anything that was presented visit or email us at info@onwd.com. *Investigational and not available for commercial use. #EmpoweringMovement #SCI #ISCoS2023"
X Link 2023-10-11T21:04Z [----] followers, [----] engagements
"Trying to put yourself in someones shoes can be a powerful way to understand empathize and gain perspective. In an effort to learn more about adaptive sports for people living with paralysis our team members experienced a taste of what its like to play basketball in a wheelchair.This week we joinedClub Fauteuil Roulant Valais Romand (The Wheelchair Club of French-speaking Valais) for a friendly matchup among ONWARD employees. Club Fauteuil Roulant Valais Romand founded in [----] is part of theSwiss Paraplegics Association.The organizations [---] members many of whom have spinal cord palsy"
X Link 2023-10-30T15:12Z [----] followers, [---] engagements
"Were wearing the white hats here and were working on harnessing the power of AI to do good. -Dave Marver CEO ONWARD Medical Thank you@CNN for your fascinating report on how AI empowers our mission and technology on The Whole Story With Anderson Cooper. Earlier this year the CNN team - which included Emmy-winning reporterNick Wattand veteran producerJessica Small- spent several days in the Netherlands and in Switzerland learning about our therapies and their applications. They also spent time with Gert-Jan Oskam the first person in the world to be implanted with a brain-computer interface"
X Link 2023-12-07T17:06Z [----] followers, [---] engagements
"Thanks to @euronext and partners Backstage Communication @bakermckenzie @Belfius @McKinsey and @PwC for hosting #EuronextIPODay in Zurich this week. Our CEO Dave Marver spoke about our IPO journey and answered questions from the audience of founders entrepreneurs and business leaders. #EuronextIPODay connects founders with business leaders to help them gain insights and explore pathways to financing their businesses. We appreciate the opportunity to share our experience to support innovation. We became a public company in October [----] and since that time we have made substantial progress on"
X Link 2023-12-14T17:36Z [----] followers, [---] engagements
"We are thrilled to share the launch of the HemON NL clinical feasibility study at @maartenskliniek in Nijmegen the Netherlands. ๐ The start of HemON NL moves us one step closer to expected initiation of a global pivotal trial called Empower BP which is designed to provide the evidence necessary to submit a pre-market approval (PMA) to the US Food and Drug Administration (FDA) and other global regulatory authorities. This trial builds upon the Swiss HemON clinical feasibility study addressing the critical issue of hemodynamic instability after spinal cord injury (SCI). In late [----] a study"
X Link 2024-01-19T21:58Z [----] followers, [---] engagements
"โจ Thanks to De [--] the podcast from Dutch newspaper @tijd for its deep dive on brain-computer interface (BCI) technology. The episode which was in Dutch examined the buzz behind last weeks news about @neuralink's first human implant what it means and the opportunities for investors. The show also laid out the events leading up to the news and noted this is not a first the Dutch company ONWARD already implanted one BCI several years ago. Education around new scientific breakthroughs is vital to continue progress and prevent misinformation. We appreciate journalists who help the public learn more"
X Link 2024-02-05T21:18Z [----] followers, [---] engagements
"โจ Thanks to De [--] the podcast from Belgian newspaper @tijd for its deep dive on brain-computer interface (BCI) technology. The episode which was in Dutch examined the buzz behind last weeks news about @neuralink's first human implant what it means and the opportunities for investors. The show also laid out the events leading up to the news and noted this is not a first the Dutch company ONWARD already implanted one BCI several years ago. Education around new scientific breakthroughs is vital to continue progress and prevent misinformation. We appreciate journalists who help the public learn"
X Link 2024-02-05T23:55Z [----] followers, [---] engagements
"๐ Congratulations to our Vice President Clinical Regulatory & Quality Dr. Erika Ross Ellison for her recent election as President of the @IEEEembs the worlds largest international society of biomedical engineers. We proudly celebrate Erikas historic achievement. Her election marks the first time in the 72-year history of IEEE EMBS that a leader from industry will serve in this volunteer position. Erika will be the 7th woman in the societys history to lead the organization. IEEE EMBS is driven by a mission to create innovations in healthcare technology for the benefit of all humanity. The"
X Link 2024-02-08T16:19Z [----] followers, [---] engagements
"Have questions about the brain-computer interface (BCI) landscape If so read on for our take on the fast-moving BCI ecosystem and what sets us apart. โก Unlike pure-play BCI companies focused on developing technology to help a paralyzed person communicate with a computer mouse keyboard or voice generator we are advancing BCI technology to control our investigational implantable ARC-IM spinal cord stimulation therapy that is designed to restore thought-driven movement of the human body after paralysis. โก The BCI we are using in clinical feasibility studies pairs ARC-IM Therapy with a BCI from"
X Link 2024-02-14T18:30Z [----] followers, [---] engagements
"The Brain-Computer Interface (BCI) system is a breakthrough technology enabling communication between the brain and the spinal cord offering the potential for a person to regain movement in arms or legs after paralysis. This investigational system has already empowered individuals with spinal cord injuries (SCI) to improve their mobility as part of ongoing clinical studies. ONWARD Medical in collaboration with the other Reverse Paralysis Project members invites you to share your insights to help us shape the development of this technology. Survey Details: Target Audience: People with a spinal"
X Link 2024-02-27T16:47Z [----] followers, [----] engagements
"Hello Greg Thank you for your question. ARC Therapy is currently in development for use via a transcutaneous (external through the skin) platform called ARC-EX and an implantable platform called ARC-IM which includes combination use with a brain-computer interface (BCI). Both of these platforms are for investigational use only and are not currently available for sale. We are working hard to finalize development so that we can apply for regulatory approval to make these platforms widely available. Stay tuned"
X Link 2024-03-01T18:15Z [----] followers, [--] engagements
"Thanks to@ardivleugels and@mvanpoll of Dutch financial newspaper@FD_Nieuws for your informative examination of the brain-computer interface (BCI) ecosystem. The article written in Dutch thoughtfully explores the various applications for BCI technology and highlights our unique role in using BCIs paired with our ARC-IMTherapy to help people with spinal cord injury (SCI) move again through the power of thought. The landscape of BCI technology is complex and competitive. Given the attention and hype around BCIs we are thankful for informative pieces that reach beyond the buzzy headlines and"
X Link 2024-03-07T17:58Z [----] followers, [---] engagements
"โจ Thanks to@SeanWhooleyWTWH of@MassDevice for highlighting our 10thBreakthrough Device Designation awarded by the US Food and Drug Administration and for informing readers about our work with brain-computer interface (BCI) technology. This latest award is for our ARC-BCISystem which uses BCI technology in conjunction with our investigational ARC-IM neuromodulation platform to restore thought-driven lower limb mobility after spinal cord injury (SCI). We are proud to be the first company in the world to receive breakthrough designation for a BCI paired with therapeutic stimulation which"
X Link 2024-03-07T18:11Z [----] followers, [---] engagements
"๐ We have just been accepted into the US FDAs new Total Product Lifecycle Advisory Program (TAP) which provides us with streamlined US regulatory review for our investigational ARC-BCI System. We are thrilled to be the second brain-computer interface (BCI) company to be accepted into the program alongside @PrecisionNeuro7. What does this mean Access to the fastest FDA review times for new medical technology. Early and frequent strategic engagement from the FDA people in the spinal cord injury (SCI) Community providers and payors to facilitate more rapid development and widespread patient"
X Link 2024-03-11T17:14Z [----] followers, [----] engagements
"Today we shared our [----] strategic priorities and we have an exciting year ahead Our top priority is commercialization and we look forward to bringing the first-ever therapy that can improve upper limb strength and function - even years after a spinal cord injury (SCI) to the SCI Community in the US later this year.* Heres more detail: โก ARC-EX commercial launch. We expect to launch our investigational ARC-EX System to improve the strength and function of the upper extremities after SCI in the US in Q4 [----]. Major associated milestones this year include US FDA De Novo submission FDA clearance"
X Link 2024-03-15T15:53Z [----] followers, [---] engagements
"We are getting ready to meet you at the VFB Happening on Saturday March 23rd The event organized by the @VlFedBeleggers is taking place in Kinepolis Antwerpen. Free registration: Join our presentation at 10:00 am in Speaker Corner I. Our CEO Dave Marver will be sharing important updates about how ONWARD Medical is revolutionizing therapies for spinal cord injury (SCI). You will learn more about our two investigational breakthrough neurostimulation platforms that are designed to restore movement function and independence in people living with SCI. Please visit us at Booth #1001 to say hello"
X Link 2024-03-20T04:18Z [----] followers, [---] engagements
"We ended an important week for ONWARD Medical by reconnecting with Belgian investors at Saturdays annual VFB Happening organized by the @VlFedBeleggers. Since our IPO on Euronext Brussels in [----] we have prioritized sharing frequent and transparent updates with the retail investor community. Our CEO Dave Marver personally joined the event in Antwerp to present our recent achievements and answer questions about several upcoming milestones. Following his talk investors engaged our team in discussions about our latest progress toward commercialization of our compelling investigational ARC"
X Link 2024-03-27T14:22Z [----] followers, [---] engagements
"โจOur trial participants are trailblazers. Many signed up for our studies involving ARC Therapy to support innovation for the spinal cord injury (SCI) community. Jessie Owen is one of those trailblazers. She had been injured for [--] years when she found a study evaluating ARC-EX Therapy.Youll hear more about her journey in the coming weeks but we wanted to give you a snapshot of Jessies wisdom and experience and the hope she might bring to others.๐ *ONWARD ARC-EX Therapy is an investigational therapy designed to non-invasively stimulate the spinal cord to aid in functional recovery after SCI"
X Link 2024-04-18T19:38Z [----] followers, [---] engagements
"๐Congratulations to our research partners and @_NeuroRestore co-directors @gcourtine and @Jocelyne_Bloch for being named to [----] TIME100 Health TIMEs inaugural list of the [---] most influential people in global health this year.๐ @TIME honored the pair for their breakthrough technology that restores communication between the brain and the spinal cord after spinal cord injury (SCI). Check out the article: #EmpoweringMovement #SCI #TIME100HEALTH All ONWARD devices and therapies including but not limited to ARC-IM ARC-EX ARC-BCI and ARC Therapy alone or in combination with a brain-computer"
X Link 2024-05-02T13:50Z [----] followers, [----] engagements
"Every step you make brings you closer to your dreams. We recently had the pleasure of welcoming Belgian keynote speaker @marctri185 in our Lausanne office. His visit touched us and Marc deeply as it ignited his own dream To Walk Again. For more than [--] years since his own spinal cord injury Marc has trained every day at the highest level hoping that one day there will be new breakthrough therapies available. His determination inspires our team and reminds us of the urgency behind our work. Marc told us about the positive shift in attitudes toward spinal cord injuries (SCI) that he has"
X Link 2024-05-07T20:37Z [----] followers, [---] engagements
"๐At ONWARD Medical were not just about innovation -- we're about impact. Every important moment and every breakthrough on our journey as a company have been fueled by the stories of strength perseverance and hope for progress in the spinal cord injury community. ๐น This is a story of what moves us what we stand for and how we envision the future. While our story to-date shows the impact our investigational therapies have had during clinical trials we are on a mission to broaden that impact. We hope youll join our journey. ๐ซ Follow our movement at http://ONWD.com http://ONWD.com"
X Link 2024-05-13T14:26Z [----] followers, [---] engagements
"๐ We are looking forward to sharing more details about our Up-LIFT pivotal trial results which were published in @Nature Medicine this week. On Thursday May 23rd at 2:30pm CET/8:30am ET following a brief Q1 Business Update CEO Dave Marver will host a discussion of Up-LIFT pivotal trial results with a panel of principal investigators and participants. Up-LIFT demonstrated the safety and effectiveness of external ONWARD ARC-EX Therapy to improve hand and arm function after spinal cord injury. Panelists will include Up-LIFT principal investigators Drs. Jim Guest Chet Moritz and Candy"
X Link 2024-05-21T18:25Z [----] followers, [---] engagements
"๐On the heels of our groundbreaking publication of our Up-LIFT pivotal trial results in@Nature Medicine last week Drs. Edelle Field-Fote of @ShepherdCenter and Candy Tefertiller of @CraigHospitalour Up-LIFT and LIFT Home study investigators presented results from these two clinical trials this week at the Amercian Spinal Injury Association (ASIA)2024 Annual Scientific Meeting. We also appreciated the advice that many dedicated SCI professionals shared with us for executing upcoming clinical trials and introducing and integrating our therapies into clinical practice once we are cleared for"
X Link 2024-05-28T15:56Z [----] followers, [---] engagements
"๐ Congratulations to @neurokinex for presenting results from its investigator-initiated clinical study using investigational ARC-EX Therapy at the [----] AMERICAN SPINAL INJURY ASSOCIATION (ASIA) Annual Scientific Meeting last month. The poster was presented by our very own Jenny Suggitt who was the lead investigator for the Neurokinex study* before joining ONWARD Medical in [----]. The poster focused on five participants with thoracic spinal cord injuries who began the study with lower limb mobility and function challenges including trunk stability walking and standing independently. Study"
X Link 2024-06-24T19:44Z [----] followers, [---] engagements
"๐Congratulations to our research partners @_NeuroRestore co-directors @gcourtine and @Jocelyne_Blochfor delivering the closing plenary lecture at the #FENS2024Forum in Vienna Austria. The duo spoke to the enthusiastic audience at the Federation of European Neuroscience Societies (@FENSorg) conference about the therapies they have developed to address the unmet needs of people with spinal cord injury (SCI). The FENS Forum is Europes largest #neuroscience congress covering all areas of the field from basic to translational research and highlighting the most up-to-date research discoveries in"
X Link 2024-07-09T19:51Z [----] followers, [----] engagements
"๐ We recently published our Annual #Sustainability Summary which describes new measures we have put in place to continue strengthening our sustainability approach. These measures include: โ
An assessment to focus the companys sustainability resources where most impactful โ
New policies in stakeholder dialogue environmental management and data privacy โ
Codes of conduct for interactions with third-parties The report also highlights our performance across a set of sustainability indicators: We were rated top 40% in our industry for sustainability performance by @ecovadis the worlds largest"
X Link 2024-07-18T16:37Z [----] followers, [---] engagements
"โจ Our research partners .NeuroRestore co-directors G. Courtine and Jocelyne Bloch were thrilled to celebrate the opening ceremonies of the [----] Olympics in Paris last week. The pair was invited by Presence Suisse a Swiss government-based group that showcases Swiss innovation and inclusiveness abroad. We celebrate opportunities to highlight Swiss innovation and connect with our friends in France and those all over the world through the Olympics and beyond. ๐ #EmpoweringMovement #SCI #ParisOlympics Note: All ONWARD Medical devices and therapies including but not limited to ARC-IM ARC-EX"
X Link 2024-07-31T14:45Z [----] followers, [---] engagements
"Congratulations to our own VP Global Clinical Regulatory and Quality Erika Ross Ellison for sharing insights about our work with brain-computer interface (BCI) technology at the recent @IEEEembs in Orlando Florida. Erika who is President-Elect of IEEE EMBS spoke on a panel titled BCI State of the Art Art of the Future. She discussed our groundbreaking work using a DigitalBridge. Erika was joined by executives from @BlackrockNeuro_ @motifneuro @paradromics and @PNNResearch to discuss the future of #BCI technology. #EmpoweringMovement #SCI #BCI #DigitalBridge *All ONWARD Medical devices and"
X Link 2024-08-05T16:00Z [----] followers, [---] engagements
"๐ We just reached the Panel Picker phase of the SXSW submission process and we NEED your votes to bring our proposed panel to @sxsw 's iconic gathering of innovators and creatives Please vote for our proposed panel in partnership with the @ReeveFoundation called SCI Research: One Small Movement Can Change Lives. This exciting conversation will feature the Reeve Foundations Chief Scientific Officer Dr. Marco Baptista our own CEO Dave Marver and @NeurotechNetwk and CEO Jennifer French. The discussion would be moderated by @NBCNews correspondent Ellison Barber. Heres how to vote for our"
X Link 2024-08-07T17:03Z [----] followers, [---] engagements
"๐ Thank you @U2FP_CureSCI the podcast from United [--] Fight Paralysis (U2FP) for shining a light on the potential for investigational ARC-EX Therapy to address upper limb mobility and strength challenges after spinal cord injury (SCI). In ONWARD to Recovery U2FP CureCast co-host @rodreickit interviewed our CEO Dave Marver in an illuminating conversation about our company our research our therapies and our Up-LIFT pivotal trial results. Matthews thoughtful questions and observations made for a robust conversation. ๐ค Link to podcast: ONWARD to Recovery (Episode 105) #EmpoweringMovement #SCI"
X Link 2024-08-21T15:40Z [----] followers, [---] engagements
"๐ฃ Dr. Candace Tefertiller - DPT PhD principal investigator (PI) of our Up-LIFT pivotal trial* lead PI for our LIFT Home study** and Executive Director of Research and Evaluation at @CraigHospital - delivered a thoughtful podium presentation on the Up-LIFT pivotal trial* results to packed and engaged audience at the @PVA1946 (PVA) Summit + EXPO. Dr. Tefertiller shared the following results from the LIFT Home** study: โก Participant dedication to the trial and therapy - participants completed all [--] investigational ARC-EX Therapy sessions at home (3 sessions a week). โก Participant ability to"
X Link 2024-08-28T18:57Z [----] followers, [---] engagements
"We are proud to announce a grant from the @ReeveFoundation to further support our research using brain-computer interface (BCI) technology The Reeve Foundations $1.1M grant to our research partner and study sponsor @_NeuroRestore expands an ongoing early clinical feasibility study exploring the use of a BCI to restore thought-driven use of the hands and arms after SCI. The new grant from the Reeve Foundation enables up to four additional participants to be implanted with the investigational ONWARD ARC-BCI System. ๐ This ongoing study is also supported by the @EUeic European Innovation"
X Link 2024-09-03T15:45Z [----] followers, [---] engagements
"โจThank you Canton de Vaud and Tech Tour for hosting the 15th Annual Tech Tour Growth Health Programme a gathering of leading life science innovators this week at the beautiful Olympic Museum. Our own CEO Dave Marver gave a keynote to the audience of top European venture capital firms senior business leaders and industry experts. He spoke about our companys vision our progress towards our commercial goals and why Lausanne has been so critical to our journey we were founded there many of our engineers and scientists were trained at @EPFL_en we conduct research at the @CHUVLausanne and our most"
X Link 2024-09-12T15:14Z [----] followers, [---] engagements
"๐ Congratulations to @ISCoS Meetings for its memorable 63rd ISCoS Annual Scientific Meeting in Antwerp Belgium. We were a proud sponsor of the event and several of our leaders including our VP Clinical Regulatory and Quality Erika Ross Ellison and our VP Engineering Julien Camisani attended this influential conference. Our highlights included: Dr. Candace Tefertiler DPT PhD principal investigator (PI) of our Up-LIFT pivotal trial* lead PI for our LIFT Home study** and Executive Director of Research and Evaluation at Craig Hospital of Denver Colorado USA presented results from the LIFT Home"
X Link 2024-10-02T15:46Z [----] followers, [---] engagements
"๐ Kudos to United to Fight Paralysis (U2FP) for the success of its 19th Annual Science & Advocacy Symposium in Atlanta despite special weather challenges this year ๐จ We were thrilled to sponsor this event and we joined scientists clinicians investors those with spinal cord injury (SCI) and their caregivers over the weekend to share the work we are doing to address the unmet needs of the SCI Community. Our CEO Dave Marver and James D. Guest - MD PhD FAANS Professor at the University of Miami and the Miami Project to Cure Paralysis and principal investigator of our Up-LIFT pivotal study spoke"
X Link 2024-10-03T13:30Z [----] followers, [---] engagements
"โจ Thanks to Mass Device and Sean Whooley for an informative piece detailing our work with brain-computer interface (BCI) technology. The article covered our recent announcement of a third successful implant of our investigational ARC-BCI Therapy to restore thought-driven movement after spinal cord injury (SCI). This milestone event which involved the use of our investigational ARC-BCI System to restore lower limb mobility after SCI is part of an ongoing clinical feasibility study supported by grants from the Christopher & Dana Reeve Foundation and the European Innovation Council and in"
X Link 2024-10-08T09:35Z [----] followers, [---] engagements
"Were excited to share that @LeFigaroBourse has highlighted the recent announcement of our exclusive license with @CEA_Officiel. Our #BCI research leverages the world-class expertise of #Clinatec and @_NeuroRestore and is funded by the @ReeveFoundation and the @EU_EISMEA. Please note: All ONWARD Medical devices and therapies including ARC-IM ARC-EX ARC-BCI and ARC Therapy alone or in combination with a brain-computer interface (BCI) are investigational and not yet available for commercial use. #EmpoweringMovement #SCI #BCI"
X Link 2024-10-17T21:04Z [----] followers, [---] engagements
"We are delighted to share that we have raised EUR [--] million in new funding led by a cornerstone investment from @ottobockHQ_de a global leader in prosthetics orthotics and exoskeleton technology with [----] employees and operations in almost [--] countries. Thank you to our advisors at @UBS @SkaddenArps @BGequity @NautaDutilh @degroofpetercam and @KBCSecurities for assisting with this transaction. This additional capital will help us achieve our mission to restore movement function and independence to the millions of people with spinal cord injuries and movement disabilities around the globe."
X Link 2024-10-24T06:25Z [----] followers, [---] engagements
"๐Three years ago we made history with the largest pre-revenue medtech IPO in Europe.ever. Since then weve been on an incredible journey fueled by a strong team loyal investors and committed partners. Weve grown from a promising startup to a company on the brink of commercialization. As we reflect on the milestones since our Euronext public listing in October [----] were excited to share some of our most notable achievements. ๐ซ Note: All ONWARD Medical devices and therapies including but not limited to ARC-IM ARC-EX ARC-BCI and ARC Therapy alone or in combination with a brain-computer"
X Link 2024-10-28T17:21Z [----] followers, [----] engagements
"๐ซ Scientific innovation in #neurotech took the world diplomatic stage last month as our co-founders and advisors neuroscientist @gcourtine and neurosurgeon @Jocelyne_Bloch addressed the @UN Security Council. The pair shared their knowledge about the latest breakthroughs in brain-computer interface (BCI) technology leveraging their groundbreaking work developing a DigitalBridge to enable though-driven movement after paralysis. The Security Council discussed how scientific developments can contribute to global peace and security. Swiss Federal Councillor @ignaziocassis chaired the meeting"
X Link 2024-11-07T20:01Z [----] followers, [---] engagements
"๐ We are excited to discuss our mission our therapies and our roadmap at Web Summit [----] next week in Lisbon Portugal. Our CEO Dave Marver will join Adrien Cohen of SCI Ventures for the November 12th panel about how investing can help address the unmet needs of those with #spinalcordinjury (SCI). @KWardTV of @globalnews will moderate the discussion about translating these #medtech breakthroughs from the lab to the clinic. Thank you Web Summit for shining a light on these innovative therapies for the SCI Community. We look forward to a thoughtful conversation๐ก Note: All ONWARD Medical"
X Link 2024-11-09T03:34Z [----] followers, [---] engagements
"๐ Come join us at Belgiums largest investor event Finance Avenue on Saturday November 16th โจThere are plenty of opportunities to learn more about our innovative solutions and upcoming plans. Global Marketing Director Rob Nijs will host Invest in Empowering Movement: ONWARD Medical is Ready to Revolutionize Therapies for People with Spinal Cord Injury a workshop about our breakthrough therapies. You can also swing by our booth to ask Rob your questions. Special thanks to Belgium publications @tijd and @lecho for organizing this noteworthy event ๐ฐ ๐ Registration link in the comments."
X Link 2024-11-14T18:36Z [----] followers, [---] engagements
"๐ We are excited to announce a grant from the @EUeic to study the potential for our investigational ARC-BCI System with brain-computer interface (BCI) technology and artificial intelligence (AI) to restore upper limb movement after subcortical stroke. While helping people with spinal cord injury (SCI) remains our North Star this grant underscores the potential for our breakthrough therapies to impact people with other movement disabilities such as stroke which affects approximately [--] million people worldwide each year per the @WorldStrokeOrg . Here are the headlines: โก The grant will"
X Link 2024-11-19T06:45Z [----] followers, [---] engagements
"๐ Today marks a truly historic moment not just for our company but for the entire spinal cord injury (SCI) community. After more than a decade of pioneering research and unwavering dedication we have received FDA de novo classification and authorization to market the ARC-EX System the world's first non-invasive spinal cord stimulation system proven to improve strength and sensation after chronic SCI. ๐ซ Here are some key highlights of the ARC-EX System: 90% of clinical trial participants showed improved strength or function* in clinical trials Benefits seen up to [--] years post-injury* in"
X Link 2024-12-19T17:39Z [----] followers, [----] engagements
"โจ We wanted to highlight an incredible story of transformation and hope. ๐ Jessie Owen is one of our pioneering ARC-EX Therapy trial participants. Jessie who lives in Seattle learned about ARC-EX Therapy after connecting with Chet Moritz PhD Professor of Rehabilitation Medicine at the University of Washington. Jessie learned about our therapy during a dark time in her life five years after suffering a spinal cord injury from a horrific accident. Today Jessie says she has never been so happy in her life as she is today. Jessies journey back to joy is nothing short of awe-inspiring. ๐๐ We"
X Link 2025-01-08T21:39Z [----] followers, [---] engagements
"โจ Thank you to Seattles @NPR station @KUOW for highlighting the first sale of our ARC-EXSystem to the @UWMedicine Harborview Medical Center. In the piece journalist @NoelGasca marked the journey of trial participant Jessie Owen who was injured in an accident more than a decade ago. Jessie eventually connected with University of Washington professor and Up-LIFT clinical trial principal investigator Dr. Chet Moritz and signed up for a study involving the use of ARC-EX Therapy. Upon receiving the therapy Jessie noticed meaningful improvements in her ability to complete everyday tasks like"
X Link 2025-01-22T20:21Z [----] followers, [---] engagements
"We want to make it easier for US investors to participate in our growth We have established a sponsored Level [--] ADR program in the US under the ticker symbol ONWRY allowing investors to trade in US dollars and US-traded instruments. We have also upgraded to the @OTCMarkets where US investors can trade our ADRs under the ticker $ONWRY. This new trading option comes at an important time as the Company builds momentum resulting from the recent FDA approval of our ARC-EX System. That approval drove high-profile US media coverage on @ABC @GMA @chicagotribune and @Newsweek. Special thanks to"
X Link 2025-04-24T14:21Z [----] followers, [---] engagements
"We are pleased to share the story about Walk The Line Recovery Therapy which is one of the first US clinics to use our ARC-EX System to improve hand sensation and strength after a spinal cord injury ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinicto improve hand sensation and strengthin individuals between [--] and [--] years old that present with a chronic non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8"
X Link 2025-07-22T06:35Z [----] followers, [---] engagements
"We are proud to return to the Paralyzed Veterans of America Healthcare Summit + Expo [----] supporting this important event for the SCI MS and ALS communities as a Gold Sponsor. Held from August 24-27 in New Orleans the summit offers a unique opportunity to learn share and engage with clinicians and professionals across multiple disciplines fostering an integrated approach to care. If youre attending the conference mark your calendar: ONWARD will host an expert session and live Q&A on August [--] at 12PM. We will discuss the early real-world experience with the ARC-EX System the first and only"
X Link 2025-08-23T13:48Z [----] followers, [---] engagements
"โจ We are pleased to announce that @KBCSecurities has initiated research coverage of our company with a Buy rating and Target Price of EUR [-----] a 161% premium to yesterdays closing price. KBC Securities is part of the KBC Groupa leading Belgian integrated bank-insurance group.The initiation reports states that ourattractive commercial positioning could unlock a significant growth story in the coming years andthat recent attention to the brain-computer interface space could attract further interest in the (investment) case. We appreciate that KBC Securities recognizes the value-generating"
X Link 2024-02-12T16:08Z [----] followers, [---] engagements
"๐ The @APTA_official Combined Sections Meeting (CSM) was a success and were grateful to have been part of it A big thank you to everyone who stopped by our booth to learn about our latest innovations. ๐ It was amazing to connect and re-connect with so many mission-driven individuals with a shared passion for advancing the future of spinal cord injury and other movement disabilities. ๐ก Did you miss us at the conference and want to learn more about ONWARD Medical and our innovations Complete this webform: A special thanks to Blake and Mary Beth for representing ONWARD and making the event"
X Link 2025-02-19T17:09Z [----] followers, [---] engagements
"We are delighted to announce the appointment of Lucas Buchanan as a non-executive member of our Board of Directors $ONWD $ONWRY https://ir.onwd.com/static-files/5c019c5c-40e0-4554-9451-d0f4d4379793 https://ir.onwd.com/static-files/5c019c5c-40e0-4554-9451-d0f4d4379793"
X Link 2025-08-06T07:29Z [----] followers, [---] engagements
"Today we announced that two additional individuals living with spinal cord injuries have received our investigational ARC-BCI Therapydeveloped to restore thought-driven movement in people living with spinal cord injuries and other movement disabilities. https://ir.onwd.com/static-files/48e1c5b9-e843-4895-ac81-e0e936a841e2 https://ir.onwd.com/static-files/48e1c5b9-e843-4895-ac81-e0e936a841e2"
X Link 2026-01-22T13:51Z [----] followers, [----] engagements
"RT @ReeveFoundation: Dont miss our upcoming webinar with @onwdempowered ๐ Research update: The Empower BP study is launching ๐ Wednesday"
X Link 2025-09-18T11:28Z [----] followers, [--] engagements
"We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System.This approval allows the initiation of Empower BP a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technologyin addressingblood pressure instabilityfollowingspinal cord injury. Many people living with #SCI experience symptomatic blood pressure instability where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. This underappreciated and unmet needhas a significant"
X Link 2025-09-19T11:29Z [----] followers, [---] engagements
"We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System.This approval allows the initiation of Empower BP a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technologyin addressingblood pressure instabilityfollowingspinal cord injury. Many people living with #SCI experience symptomatic blood pressure instability where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. This underappreciated and unmet needhas a significant"
X Link 2025-09-19T11:30Z [----] followers, [---] engagements
"๐งVanguards of Health Care: Onward Medical Brings Hope Back for SCI https://www.bloomberg.com/news/audio/2025-10-02/vanguards-of-health-care-onward-medical-revives-hope-for-sci https://www.bloomberg.com/news/audio/2025-10-02/vanguards-of-health-care-onward-medical-revives-hope-for-sci"
X Link 2025-10-06T09:43Z [----] followers, [---] engagements
"Portzamparc BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR [-----] $ONWD $ONWRY https://ir.onwd.com/static-files/21395782-fe30-4069-b66b-8a297bab5af1 https://ir.onwd.com/static-files/21395782-fe30-4069-b66b-8a297bab5af1"
X Link 2025-10-08T06:08Z [----] followers, [---] engagements
"ONWARD Medical Successfully Raises Over EUR [--] Million in Capital Increase https://ir.onwd.com/news-disclaimer https://ir.onwd.com/news-disclaimer"
X Link 2025-10-24T10:22Z [----] followers, [---] engagements
"We are pleased to join the Stifel Healthcare Conference this week in New York City. ONWARD CEO @onwddave will present the latest achievements across our three purpose-built spinal stimulation technology platforms designed to restore movement function and independence in people living with spinal cord injuries and other movement disabilities. We look forward to connecting with leading US institutional investors there"
X Link 2025-11-11T08:59Z [----] followers, [---] engagements
"We are pleased to announce thatwe have received clearance to expand the ARC-EX System indication for home use in the US. The Food and Drug Administrationhas cleared the ARC-EX System for use in conjunction with functional task practice in the clinic and take-home exercises in the home to improve hand strength and sensation in adults with spinal cord injury. The ARC-EX System is intended to be operated in medical centers byrehabilitation professionalsand at home bypatientsandpersons providing assistancetopatients as needed. https://ir.onwd.com/static-files/cb47b7af-6775-469f-b4f4-cb660b8731c3"
X Link 2025-11-17T07:46Z [----] followers, [----] engagements
"ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 [----] @onwddave CEO of ONWARD Medical said: We continued to deliver strong commercial execution in Q3 and we achieved several meaningful scientific and regulatory milestones across our technology platforms. Home-based ARC-EX Therapy greatly enlarges the US market opportunity and helps fulfill our mission to provide the SCI community with broad and convenient access to innovative therapies. We are also well positioned to initiate Empower BP our second global pivotal study and the"
X Link 2025-11-24T07:56Z [----] followers, [---] engagements
"We are delighted to attend the 37thPiper Sandler Annual Healthcare Conference this week in New York City. ONWARD CEO @onwddave will share key updates on our commercial execution. He will also highlight recent scientific and regulatory milestones as we advance our three purpose-built spinal stimulation technology platforms developed to restore movement function and independence for people living with spinal cord injuries. We look forward to connecting with leading US institutional investors there"
X Link 2025-12-01T12:41Z [----] followers, [---] engagements
"ONWARD CEO @onwddave joined renowned science journalist @RangaYogeshwar on the latest episode of @ottobockHQ_en "Taste of Bionics" podcast. Together they explored how we are pioneering therapies to restore movement function and independenceafter spinal cord injury. ๐งTune into hear about: - Breakthroughs in external spinal cord stimulationto improve hand strength and sensation - Advances in implantable neurostimulation technology to address blood pressure instability after SCI - How brain-computer interface technology can make thought-driven movement a reality for people living with paralysis"
X Link 2025-12-08T10:28Z [----] followers, [---] engagements
"Werepleased to announce that our ARC-EX System has recently receivedULMarkcertification a globally recognized symbol of product safety and quality. The ARC-EX System is the first and only US FDA-cleared technology indicated to improve hand sensation and strength after a spinal cord injury. ThisULcertification andauthorization to label our product with theULMarkconfirm that our system meets rigorous safety standards.It underscores our commitment to excellence in developing innovative technologies that restore movement function and independence for people living with #SCI and other movement"
X Link 2025-12-17T17:38Z [----] followers, [---] engagements
"Were delighted to attend the 44th Annual J.P. Morgan Healthcare Conference next week in San Francisco. We look forward to connecting with investors and innovators to discuss the latest achievements and developments across our three purpose-built spinal cord stimulation platforms to restore movement function and independence in people with spinal cord injuries and other movement disabilities. @onwddave"
X Link 2026-01-09T14:51Z [----] followers, [---] engagements
"We are pleased to announce theenrollment of the first participant in Empower BPaglobal pivotal study assessing the safety and effectiveness of the investigational ARC-IMSystem in managing symptomatic blood pressure instability in people with chronic spinal cord injury.The study is expected to involve participants across approximately [--] leading neurorehabilitation and neurosurgical research centers in the US Canada France Germany Spain and the UK. The first participant was enrolled at Craig Hospital in Denver Colorado. The initiation ofEmpower BP marks another significant milestone in our"
X Link 2026-02-04T08:29Z [----] followers, [---] engagements
"We are pleased to announce theenrollment of the first participant in Empower BPaglobal pivotal study assessing the safety and effectiveness of the investigational ARC-IMSystem in managing symptomatic blood pressure instability in people with chronic spinal cord injury.The study is expected to involve participants across approximately [--] leading neurorehabilitation and neurosurgical research centers in the US Canada France Germany Spain and the UK. The first participant was enrolled at Craig Hospital in Denver Colorado. The initiation ofEmpower BP marks another significant milestone in our"
X Link 2026-02-04T08:29Z [----] followers, [---] engagements
"Today we announced that two additional individuals living with spinal cord injuries have received our investigational ARC-BCI Therapydeveloped to restore thought-driven movement in people living with spinal cord injuries and other movement disabilities. https://ir.onwd.com/static-files/48e1c5b9-e843-4895-ac81-e0e936a841e2 https://ir.onwd.com/static-files/48e1c5b9-e843-4895-ac81-e0e936a841e2"
X Link 2026-01-22T13:51Z [----] followers, [----] engagements
"Were delighted to attend the 44th Annual J.P. Morgan Healthcare Conference next week in San Francisco. We look forward to connecting with investors and innovators to discuss the latest achievements and developments across our three purpose-built spinal cord stimulation platforms to restore movement function and independence in people with spinal cord injuries and other movement disabilities. @onwddave"
X Link 2026-01-09T14:51Z [----] followers, [---] engagements
"Werepleased to announce that our ARC-EX System has recently receivedULMarkcertification a globally recognized symbol of product safety and quality. The ARC-EX System is the first and only US FDA-cleared technology indicated to improve hand sensation and strength after a spinal cord injury. ThisULcertification andauthorization to label our product with theULMarkconfirm that our system meets rigorous safety standards.It underscores our commitment to excellence in developing innovative technologies that restore movement function and independence for people living with #SCI and other movement"
X Link 2025-12-17T17:38Z [----] followers, [---] engagements
"ONWARD CEO @onwddave joined renowned science journalist @RangaYogeshwar on the latest episode of @ottobockHQ_en "Taste of Bionics" podcast. Together they explored how we are pioneering therapies to restore movement function and independenceafter spinal cord injury. ๐งTune into hear about: - Breakthroughs in external spinal cord stimulationto improve hand strength and sensation - Advances in implantable neurostimulation technology to address blood pressure instability after SCI - How brain-computer interface technology can make thought-driven movement a reality for people living with paralysis"
X Link 2025-12-08T10:28Z [----] followers, [---] engagements
"We are delighted to attend the 37thPiper Sandler Annual Healthcare Conference this week in New York City. ONWARD CEO @onwddave will share key updates on our commercial execution. He will also highlight recent scientific and regulatory milestones as we advance our three purpose-built spinal stimulation technology platforms developed to restore movement function and independence for people living with spinal cord injuries. We look forward to connecting with leading US institutional investors there"
X Link 2025-12-01T12:41Z [----] followers, [---] engagements
"ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 [----] @onwddave CEO of ONWARD Medical said: We continued to deliver strong commercial execution in Q3 and we achieved several meaningful scientific and regulatory milestones across our technology platforms. Home-based ARC-EX Therapy greatly enlarges the US market opportunity and helps fulfill our mission to provide the SCI community with broad and convenient access to innovative therapies. We are also well positioned to initiate Empower BP our second global pivotal study and the"
X Link 2025-11-24T07:56Z [----] followers, [---] engagements
"We are pleased to announce thatwe have received clearance to expand the ARC-EX System indication for home use in the US. The Food and Drug Administrationhas cleared the ARC-EX System for use in conjunction with functional task practice in the clinic and take-home exercises in the home to improve hand strength and sensation in adults with spinal cord injury. The ARC-EX System is intended to be operated in medical centers byrehabilitation professionalsand at home bypatientsandpersons providing assistancetopatients as needed. https://ir.onwd.com/static-files/cb47b7af-6775-469f-b4f4-cb660b8731c3"
X Link 2025-11-17T07:46Z [----] followers, [----] engagements
"We are pleased to join the Stifel Healthcare Conference this week in New York City. ONWARD CEO @onwddave will present the latest achievements across our three purpose-built spinal stimulation technology platforms designed to restore movement function and independence in people living with spinal cord injuries and other movement disabilities. We look forward to connecting with leading US institutional investors there"
X Link 2025-11-11T08:59Z [----] followers, [---] engagements
"Out now. Neuroscientist Grgoire Courtine is dedicated to treating spinal cord injuries. As part of our #PerpetualPlanet Initiative the #RolexAwards Laureate is helping a paralysed woman dream of returning to a Life in Motion. More on #Reachforthecrown http://bit.ly/_gregoirecourtine_ http://bit.ly/_gregoirecourtine_"
X Link 2025-10-28T10:00Z 896K followers, 16.1K engagements
"ONWARD Medical Successfully Raises Over EUR [--] Million in Capital Increase https://ir.onwd.com/news-disclaimer https://ir.onwd.com/news-disclaimer"
X Link 2025-10-24T10:22Z [----] followers, [---] engagements
"Portzamparc BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR [-----] $ONWD $ONWRY https://ir.onwd.com/static-files/21395782-fe30-4069-b66b-8a297bab5af1 https://ir.onwd.com/static-files/21395782-fe30-4069-b66b-8a297bab5af1"
X Link 2025-10-08T06:08Z [----] followers, [---] engagements
"๐งVanguards of Health Care: Onward Medical Brings Hope Back for SCI https://www.bloomberg.com/news/audio/2025-10-02/vanguards-of-health-care-onward-medical-revives-hope-for-sci https://www.bloomberg.com/news/audio/2025-10-02/vanguards-of-health-care-onward-medical-revives-hope-for-sci"
X Link 2025-10-06T09:43Z [----] followers, [---] engagements
"We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System.This approval allows the initiation of Empower BP a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technologyin addressingblood pressure instabilityfollowingspinal cord injury. Many people living with #SCI experience symptomatic blood pressure instability where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. This underappreciated and unmet needhas a significant"
X Link 2025-09-19T11:30Z [----] followers, [---] engagements
"We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System.This approval allows the initiation of Empower BP a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technologyin addressingblood pressure instabilityfollowingspinal cord injury. Many people living with #SCI experience symptomatic blood pressure instability where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. This underappreciated and unmet needhas a significant"
X Link 2025-09-19T11:29Z [----] followers, [---] engagements
"RT @ReeveFoundation: Dont miss our upcoming webinar with @onwdempowered ๐ Research update: The Empower BP study is launching ๐ Wednesday"
X Link 2025-09-18T11:28Z [----] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing